Hot Features
MabCure, Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies agai... MabCure, Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure, Inc. in January 2008 to reflect its new business plan. MabCure, Inc. was founded in 2006 and is based in White Plains, New York. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0001 | 50 | 0.0002 | 0.0003 | 0.0002 | 973 | 0.00029486 | CS |
| 4 | 0.0002 | 200 | 0.0001 | 0.0005 | 1.0E-6 | 3359 | 0.0002738 | CS |
| 12 | 0.0001 | 50 | 0.0002 | 0.0005 | 1.0E-6 | 2599 | 0.00032468 | CS |
| 26 | 0 | 0 | 0.0003 | 0.0005 | 1.0E-6 | 32008 | 0.00012011 | CS |
| 52 | 0.0002 | 200 | 0.0001 | 0.0005 | 1.0E-6 | 19938 | 0.00011669 | CS |
| 156 | 0 | 0 | 0.0003 | 0.009 | 1.0E-6 | 15851 | 0.00022415 | CS |
| 260 | -0.0106 | -97.247706422 | 0.0109 | 0.0189 | 1.0E-6 | 27434 | 0.0045192 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.